标题
Innate immune regulatory networks in hepatic lipid metabolism
作者
关键词
Innate immunity, Inflammation, Lipid metabolism, Insulin resistance, NAFLD
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-03-20
DOI
10.1007/s00109-019-01765-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
- (2018) Yan-Xiao Ji et al. NATURE MEDICINE
- Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
- (2018) Jingjing Cai et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
- (2017) Feng-Juan Yan et al. HEPATOLOGY
- USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity
- (2017) Shimin An et al. HEPATOLOGY
- Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease
- (2017) Fernando Bril et al. HEPATOLOGY
- The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance
- (2017) Quan-Yu Zhang et al. HEPATOLOGY
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
- (2017) Zahra Hoseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
- (2017) Pi-Xiao Wang et al. NATURE MEDICINE
- The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
- (2017) Peng Zhang et al. NATURE MEDICINE
- Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
- (2017) Guang-Nian Zhao et al. NATURE MEDICINE
- NASH: Novel therapeutic strategies targeting ASK1 in NASH
- (2017) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- TRIF-dependent Toll-like receptor signaling suppressesScd1transcription in hepatocytes and prevents diet-induced hepatic steatosis
- (2017) Jing Chen et al. Science Signaling
- Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism
- (2017) Ahmed Lawan et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
- (2017) Sukhpreet Singh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Dectin-1 Activation Exacerbates Obesity and Insulin Resistance in the Absence of MyD88
- (2017) Angela Castoldi et al. Cell Reports
- Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease
- (2017) Jin-Seok Byun et al. Biomed Research International
- TRIF-dependent Toll-like receptor signaling suppressesScd1transcription in hepatocytes and prevents diet-induced hepatic steatosis
- (2017) Jing Chen et al. Science Signaling
- Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease
- (2016) Swaytha Ganesh et al. Clinics in Liver Disease
- Hepatic glucose and lipid metabolism
- (2016) John G. Jones DIABETOLOGIA
- Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
- (2016) Thibaut Duparc et al. GUT
- Liver capsule: IRFs in hepatocytes: Pathophysiology
- (2016) Pi-Xiao Wang et al. HEPATOLOGY
- Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
- (2016) Irma Garcia-Martinez et al. JOURNAL OF CLINICAL INVESTIGATION
- IRF3 promotes adipose inflammation and insulin resistance and represses browning
- (2016) Manju Kumari et al. JOURNAL OF CLINICAL INVESTIGATION
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
- (2016) Ling Gao et al. JOURNAL OF HEPATOLOGY
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
- (2016) Lanfeng Xie et al. JOURNAL OF HEPATOLOGY
- The role of ER stress in lipid metabolism and lipotoxicity
- (2016) Jaeseok Han et al. JOURNAL OF LIPID RESEARCH
- Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease
- (2016) Hua Yan et al. Molecular Medicine Reports
- TAK1 regulates hepatic lipid homeostasis through SREBP
- (2016) S Morioka et al. ONCOGENE
- Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
- (2016) Hadi Khodabandehloo et al. Translational Research
- Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?
- (2016) Priya Handa et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
- (2016) Amedeo Lonardo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
- (2016) Pi-Xiao Wang et al. Nature Communications
- Effect of a p38 MAPK inhibitor on FFA-induced hepatic insulin resistance in vivo
- (2016) S Pereira et al. Nutrition & Diabetes
- Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
- (2015) Zheng Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- TRAF1 knockdown alleviates palmitate-induced insulin resistance in HepG2 cells through NF-κB pathway
- (2015) Wanlu Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease
- (2015) Guang-Nian Zhao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice
- (2015) Vishal Singh et al. Cell Metabolism
- Inflammasome activation and function in liver disease
- (2015) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
- (2015) Zheng Chen et al. Molecular Metabolism
- TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
- (2014) Sayaka Inokuchi-Shimizu et al. JOURNAL OF CLINICAL INVESTIGATION
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
- (2014) A. Chatzigeorgiou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
- (2014) Lin Jia et al. Nature Communications
- Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status
- (2014) Amandine Everard et al. Nature Communications
- Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2
- (2014) Birgit Knebel et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance
- (2013) Xin-An Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application
- (2013) Sarawut Kumphune et al. CURRENT PHARMACEUTICAL DESIGN
- Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
- (2013) Xin-An Wang et al. HEPATOLOGY
- Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance
- (2013) Xin-An Wang et al. HEPATOLOGY
- Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease
- (2013) Chrysi Koliaki et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Hepatic ERK activity plays a role in energy metabolism
- (2013) Ping Jiao et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Minireview: host defence in invasive aspergillosis
- (2013) Cornelia Lass-Flörl et al. MYCOSES
- Hepatic Extracellular Signal–Regulated Kinase 2 Suppresses Endoplasmic Reticulum Stress and Protects From Oxidative Stress and Endothelial Dysfunction
- (2013) Takehiko Kujiraoka et al. Journal of the American Heart Association
- Transient Inability to Manage Proteobacteria Promotes Chronic Gut Inflammation in TLR5-Deficient Mice
- (2012) Frederic A. Carvalho et al. Cell Host & Microbe
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
- (2012) Durba Pal et al. NATURE MEDICINE
- Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
- (2011) Timea Csak et al. HEPATOLOGY
- The interaction of hepatic lipid and glucose metabolism in liver diseases
- (2011) Lars P. Bechmann et al. JOURNAL OF HEPATOLOGY
- p38 MAPK–mediated regulation of Xbp1s is crucial for glucose homeostasis
- (2011) Jaemin Lee et al. NATURE MEDICINE
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance
- (2010) H. S. Kang et al. DIABETES
- Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse
- (2010) L.-H. Kuo et al. DIABETOLOGIA
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity
- (2010) Claudio Costantini et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Olmesartan Prevents Cardiovascular Injury and Hepatic Steatosis in Obesity and Diabetes, Accompanied by Apoptosis Signal Regulating Kinase-1 Inhibition
- (2008) Eiichiro Yamamoto et al. HYPERTENSION
- Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
- (2007) Puneet Puri et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started